Skip to main content
OpenTrials

Clinical trial condition

Neurodevelopmental Disorders

Explore clinical trials studying Neurodevelopmental Disorders. Study availability and eligibility vary by location and protocol.

4,081 public trials 628 recruiting studies
Refine in advanced search Browse all conditions

Neurodevelopmental Disorders trial results

Completed

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

NCT01552902

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Harmonex Neuroscience Research, Inc. Dothan, Alabama, United States
  • Center for Advanced Improvement Tucson, Arizona, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Shanti Clinical Trials Colton, California, United States
View all 95 locations
View Trial Details
Completed

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)

NCT01470469

Conditions
Anxiety Disorders, Anxiety, Separation, Generalized Anxiety Disorder, +5 more
Locations
  • Birmingham Research Group, Inc Birmingham, Alabama, United States
  • Dr. Joseph H. Rodd Carson, California, United States
  • Sun Valley Research Imperial, California, United States
  • Irvine Center for Clinical Research Irvine, California, United States
View all 33 locations
View Trial Details
Completed

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT01328756

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • ZNA Antwerpen, Commandant Weynsstraat 165 Campus Hoge Beuken Hoboken, Antwerp, Belgium
  • Afdeling Psychiatrie Leuven, Belgium
  • Albert-Ludwigs-Universität Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Zentralinstitut für Seelische Gesundheit Mannheim Mannheim, Baden-Wurttemberg, Germany
View all 35 locations
View Trial Details
Completed

Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT00697515

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • University of CA, Irvine Child Development Center Irvine, California, United States
  • Vince & Associates Clinical Research Overland Park, Kansas, United States
  • Center for Psychiatry & Behavioral Medicine, Inc Las Vegas, Nevada, United States
View Trial Details
Completed

Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17

NCT00784654

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Peninsula Research Associates, Inc. Rolling Hills Estates, California, United States
  • Miami Research Associates South Miami, Florida, United States
  • Vince and Associates Clinical Research Overland Park, Kansas, United States
  • CNS Healthcare Memphis, Tennessee, United States
View all 51 locations
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT03327402

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +8 more
Locations
  • Preferred Research Partners Little Rock, Arkansas, United States
  • Clinical Neuroscience Solutions Inc Orlando, Florida, United States
  • Qualmedica Research, LLC Evansville, Indiana, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details

Related conditions